1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69C2BC0A4F16B8FB265257CD300276F34
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-patient-focused-marketing-investment-and-activities-across-patient-journey?opendocument
18
19opendocument
203.227.3.146
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Patient Advocacy

Patient-Focused Marketing: Investment and Activities Across the Patient Journey

ID: 5304


Features:

19 Info Graphics

20 Data Graphics

100+ Metrics

7 Narratives


Pages/Slides: 48


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Patient-Focused Marketing: Investment and Activities Across the Patient Journey"


STUDY OVERVIEW

Market access and product success in the bio-pharmaceutical market is no longer determined by physicians alone. The growing patient influence in starting, sustaining or switching therapies has challenged marketers to invest wisely across the patient journey. Best Practices, LLC undertook this benchmark study to understand how the growing influence of patients in the bio-pharmaceutical market is impacting activities and spend for marketing interactions with patients.

Key metrics and info graphics in the study reveal:

  • Six key stages of the Patient Journey
  • Leading patient-focused activities by stage
  • Percentage of total Marketing budget that is earmarked for patient programs
  • Percentage of patient program funds spent at each stage of the journey
  • Cost of patient marketing per $1,000 in corporate revenue that programs support

This study will help companies in adopting a successful patient interaction framework to acquire, convert, support, and retain patients for their medical products.

KEY TOPICS
  • Investment in Patient-Focused Activities & Programs
  • Activities Timing across the Patient Journey

SAMPLE KEY METRICS
  • Percentage of total marketing budget allocated to patient-focused initiatives, activities and programs
  • Percentage of total patient marketing spend invested at each journey stage
  • Investment level per journey stage by benchmark segment
  • Patient-focused marketing activities that yield the best ROI (return on investment)
  • Patient marketing activities conducted at each stage of the patient journey

SAMPLE KEY FINDING
  • HCP education programs continue to dominate with 58% involved at Stage III
    (Consideration), but Internet portals assume a more important role (47%) due
    to the growing need for self-service functionality.

METHODOLOGY

Best Practices, LLC engaged 22 leaders at 19 companies through a benchmarking survey instrument. Qualitative data came from in-depth interviews with seven participants.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Consumer Products; Medical Device; Biotech; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbott; Abbvie; Apotex; AstraZeneca; Bayer Healthcare; Baxter; Biogen idec; Boehringer Ingelheim; Boston Scientific; Helsinn; Gilead; Lilly; Medtronic; Merck; Mylan; Novartis; Novo Nordisk; Sanofi; UCB

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.